AMIA 2025 Informatics Summit CME Information
Claiming CME
Instructions for claiming CME credit or a Certificate of Participation
- Follow this link to claim your credit. (Link available in March)
- In the upper, left-hand corner, select Claim Credits.
- Next, select Start your Evaluations to begin.
You have until April 14, 2025, to claim credit and download the certificate. No credit will be issued after this date.
Target Audience
The target audience for this live activity includes professionals and students engaged in translational bioinformatics, clinical research informatics, implementation informatics, and health data science.
Learning Objectives
After participating in this live activity, the learner will be able to:
- Weigh the benefits and limitations of state-of-the-art informatics approaches, theories, and methods relevant to clinical research and translational bioinformatics, implementation science, and health data science.
- Form research hypotheses and projects related to biomedical informatics based on existing datasets or on the aggregation of data from disparate sources.
- Develop and adopt best practices for streamlining and improving regulatory processes, clinical trial protocols, study costs, patient recruitment, and data collection, management, and analysis.
- Apply the latest findings from research and development of informatics applications to support biomedical research.
- Create and sustain multidisciplinary collaborations in the biomedical research community to expand access to diverse expertise, sophisticated technologies, and unique tools and resources.
Accreditation Statement
The American Medical Informatics Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The American Medical Informatics Association designates this live activity for a maximum of 21 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support
AMIA educational events are wholly funded by attendee registrations. No industry support is accepted from any ACCME-defined ineligible company for sessions that provide education credit.
Faculty
Faculty affiliations and disclosure of conflicts of interest are noted at each presentation.
Scientific Program Committee Chair, Members, and AMIA Staff
Coming soon
Disclosure & COI Mitigation Policy
As a provider accredited by the ACCME, AMIA requires that everyone who is in a position to control the content of an educational activity disclose all financial relationships with any ACCME-defined ineligible company for 24 months prior to the educational activity.
Any individual who refuses to disclose financial relationships will be disqualified from participating in the CME activity.
AMIA provides disclosure of financial relationships with ineligible companies to all learners. Individuals with no financial relationship(s) or potential conflicts of interest are also disclosed.
AMIA uses a number of methods to resolve potential conflicts of interest, including review of disclosures; limiting content of the presentation to that which has been reviewed by two or more SMEs; ensuring that all scientific research referred to conforms to generally accepted standards of experimental design, data collection, and analysis; undertaking review of the educational activity by a content reviewer to evaluate for potential bias, fair balance in presentation, evidence-based content or other indicators of integrity; monitoring the educational activity; and reviewing participant feedback to evaluate perceived commercial bias.
Financial Disclosures of Individuals Involved with Content Development
AMIA reviewed all disclosures for this activity and mitigated the potential for bias due to planners’ financial relationships with ACCME/ANCC-defined ineligible companies or its agents.
All AMIA staff involved with content development of the AMIA 2025 Informatics Summit have disclosed no relationships with ACCME- defined ineligible companies.